Back to search

Clydesdale Pharma Ltd

12009053

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
10/30
Financial
30/40
Risk
  • Current liabilities exceed current assets (-10)
  • 6 outstanding charges (-10)

Details

UNIT 3-5 CAMPBELL COURT, TADLEY, RG26 5EG
Incorporated 21/05/2019

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

46460
Wholesale of pharmaceutical goods
70229
Management consultancy activities

Officers

Dr Soumick Sikdar

director · Since 21/05/2019

MANAGING DIRECTOR

BRITISH · ENGLAND · Age 44

Also on 5 other boards

Persons with Significant Control

Sikdar Consulting Ltd

75–100% shares
75–100% votes
Appoint directors
right-to-appoint-and-remove-directors-as-trust
right-to-appoint-and-remove-directors-as-firm

3, Campbell Court, Tadley, RG26 5EG

Reg: 08277789 · Companies House · Limited Company

Notified 21/02/2024

Former PSCs

Dr Soumick Sikdar

Ceased 30/11/2021

Dr Soumick Sikdar

Ceased 21/02/2024

Charges6 outstanding

Charge
outstanding

SENECA TRADE FINANCE LTD

Created 14/03/2025Registered 14/03/2025
Charge
outstanding

SENECA TRADE FINANCE LTD

Created 15/01/2024Registered 05/02/2024
Charge
outstanding

ECAPITAL COMMERCIAL FINANCE LIMITED

Created 07/09/2023Registered 22/09/2023
Charge
outstanding

RX BRIDGE LIMITED

Created 06/07/2023Registered 13/07/2023
Charge
satisfied

HSBC UK BANK PLC

Created 14/07/2022Registered 15/07/2022Satisfied 07/03/2024
Charge
outstanding

HSBC UK BANK PLC

Created 06/07/2022Registered 08/07/2022
Charge
satisfied

HSBC INVOICE FINANCE (UK) LTD

Created 08/12/2021Registered 08/12/2021Satisfied 07/03/2024
Charge
outstanding

BARCLAYS SECURITY TRUSTEE LIMITED

Created 17/05/2021Registered 19/05/2021
Charge
satisfied

KOSEI PHARMA UK LTD. (IN LIQUIDATION) · ROBERT CHRISTOPHER KEYES AND GARETH WYN ROBERTS AS JOINT LIQUIDATORS OF KOSEI PHARMA UK LTD. (I

Created 22/04/2020Registered 27/04/2020Satisfied 03/06/2020

CompanyRankvs 283+ SIC 46460 peers
68

Financial strength93th percentile among SIC peers · 23/25
Employees89th percentile among SIC peers · 13/15
LiquidityCurrent ratio 2.47× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Rayburn Trading Company Limited
90
2Servier Laboratories Limited
90
3P & A J Cattee (Wholesale) Ltd.
90
4Hameln Pharma Ltd
90
5Day Lewis Medical Limited
90
6Kinetic Enterprises Limited
90
7Morningside Pharmaceuticals Limited
90
8A1 Pharmaceuticals Public Limited Company
90
9Greiner Bio-One Limited
90
10Trafalgar Scientific Limited
90
283Clydesdale Pharma Ltd
78
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£1.6M

Balance sheet strength

Cash

£3k

Cash in the bank

Net Current Assets

£918k

Working capital

Current Assets

£1.5M

Current Liabilities

£625k

Fixed Assets

£1.9M

Debtors

£531k

9avg. employees+4

Balance Sheet

Intangible assets£1.9M
Assets less current liabilities£2.8M
Prepared with Capium Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20252.47+£717k
20241.79+£2k
20231.96+£894k
20221.75+£11k
20211.30+£4k
20200.89—

Derived from filed accounts. Not audited figures.